To gain access to the data room and CIM, please copy and paste the link below to sign the NDA:
https://generational.tfaforms.net/4660083?DealID=a1LNw000001RwTz


2025 Revenue: $2,100,000
2025 EBITDA: $686,000
2026 Revenue (Proj.): $2,400,000
2026 EBITDA (Proj.): $855,000

Q1 2026 Revenue: $674,000 | Q1 2026 EBITDA: $325,000
TTM Revenue - $2,300,000 | TTM EBITDA $850,000

BUSINESS DESCRIPTION

Founded in 2003, this multi-location occupational health and compliance testing platform serves Southern West Virginia and Eastern Kentucky from three leased clinic facilities - providing dense regional coverage along the I-64 industrial corridor.

The business delivers a comprehensive, private-pay suite of non-diagnostic workforce compliance services mandated by DOT, OSHA, MSHA, and employer policy:

- Drug & Alcohol Testing — Pre-employment, random, post-accident, reasonable suspicion, return-to-duty, and follow-up testing under DOT and non-DOT protocols with full chain-of-custody compliance
- Occupational Physical Examinations — DOT/FMCSA physicals, pre-employment and non-DOT physicals, return-to-work and fitness-for-duty evaluations, and agency-specific protocols
- Third Party Administrator (TPA) Services — Random pool management, nationwide test collection coordination, and compliance recordkeeping for enterprise clients with multi-site needs
- Diagnostic Testing — X-ray, audiometric, pulmonary function, vision, and lab services
- Ancillary Compliance Services — Medical Review Officer (MRO) support and on-site/mobile testing coordination

All services are billed directly to employers and institutions on a private-pay basis — no insurance, no reimbursement risk, no billing complexity.

The Company serves approximately 1,000 active customers across coal, oil & gas, manufacturing, trucking, healthcare, and state/local government, with approximately 90% repeat business. Day-to-day operations are managed by experienced on-site office managers. The owner is involved only in bookkeeping and limited payroll oversight — normalized to a part-time replacement salary — demonstrating genuine operational independence.

INVESTMENT HIGHLIGHTS

- Non-Discretionary Revenue Base — Services are regulatory mandates, not elective spend. Demand is driven by DOT, OSHA, and MSHA requirements, producing stable, predictable, non-cyclical utilization.
90% Repeat Customer Revenue — ~1,000 active accounts across diversified end markets with no customer concentration.
- Private-Pay Model — No insurance billing eliminates reimbursement complexity and administrative overhead.
- Multi-Location Footprint, No Real Estate Risk — Three leased clinics with terms through 2027–2030, with extension options to 2030–2034.
- Scalable TPA Capability — Contracted service network and established compliance infrastructure support geographic expansion without significant capital investment.
- Limited Owner Dependence — Operations run independently; owner is non-clinical and out-of-market.
- Strong Unit Economics — ~33% EBITDA margins in 2025, projected to expand to ~36% in 2026 as drug testing revenue scales.
- Identified Expansion Opportunities — Management has identified additional markets along major interstate corridors.

EMPLOYEES: 12 total (7 FT / 5 PT) — includes Medical Doctor, Medical Assistants, Billing & Collections, X-Ray Technician, and Contracted Services providers

FACILITIES:
- WV (Primary) — ~4,200 sq. ft. | Lease through 2030
- WV — ~3,000 sq. ft. | Lease through 2027 (extendable to 2034)
- KY — ~1,500 sq. ft. | Lease through 2027 (extendable to 2030)

REASON FOR SALE: Owner pursuing retirement. Experienced management team in place to ensure continuity.